Praktické lékárenství – 3/2019

www.praktickelekarenstvi.cz e43 AKTUÁLNÍ FARMAKOTERAPIE ROZTROUŠENÁ SKLERÓZA – MATEŘSTVÍ A KOJENÍ PRAKTICKÉ LÉKÁRENSTVÍ challenges and future considerations for effective pharmacovigilance. Expert Rev Neuro- ther 2013; 13: 251–261. 15. Rae-Grant A, Day SG, Marrie RA Rabinstein A, Cree B, AGronseth S, G.S, Haboubi M, Halperd J, Hosey JP, Jones DE, Lisak R, Pelletier D, Potrebik S, Sitcov C, Sommers R, Sta- chowiak J, Getchius T,Shannon A, Merillat, Pringsheim T. Practice guideline recommenda- tions summary: disease-modyffying therapies for adults with sclerosis multiple sclerosis. Neurology 2018;90: 777–788. 16. Ortona E, Pierdominici M, Masseli A, Veroni C, Aloisi F, Shoenfeld Y. Sex-based differen- ces in autoimmune diseases. Ann Ist Super Sanita 2016; 52: 205–212. 17. Shingo T, Gregg C, Enwere E, Fujikawa H, Hassam R, Geary C, Cross JC, Weiss S. Preg- nancy-stimulated neurogenesis in the adult female forebrain mediated by prolactin. Sci- ence 2003; 299: 117–120. 18. Tang MW, Garcia S, Gerlag DM, Tak PP, Reedquist KA. Insight into the endocrine sys- tém and the immune system: a review of the inflammatory role of prolactin in rheuma- toid arthritis ad psoriatic arthritis. Front Immunol 2017; 8: 720. 19. Thöne J, Thiel S, Gold R, Hellwig K. Treatment of multiple sclerosis during pregnancy – safety considerations. Expert Opin Drug Saf 2017; 162: 523–534. 20. Zhornitsky S, Yong VW, Weiss S, Metz LM. Prolactin in multiple sclerosis. Mult Scler 2013; 19: 15–23. 21. Voskuhl R, Momtazee C. Pregnancy: Effect on multiple sclerosis, treatment considera- tions, and breastfeeding. Neurotherapeutics(2017) 14: 974–984. 22. http://www.olecich.cz/